Evaluation of Glycemia Control Achieved by Glargine and Lispro Versus Detemir and Aspart Insulin Regimes in Type 2 Diabetics Undergoing Surgery
Mushtaq Ahmad 1, *, Z.A Wafai2, S.K Mathur3, S Lodha4, Z.Y Khan3, Alka Bansal 3
Identifiers and Pagination:Year: 2015
First Page: 58
Last Page: 61
Publisher ID: TOCMJ-9-58
Article History:Received Date: 12/1/2015
Revision Received Date: 22/2/2015
Acceptance Date: 28/2/2015
Electronic publication date: 26/6/2015
Collection year: 2015
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
There is paucity of scientific literature regarding the clinical outcome of long lasting basal insulin and rapid acting mealtime insulin regimes in surgical situations although employed in non-surgical situations. This study has evaluated the clinical outcome of two subcutaneous split-mixed Glargine+Lispro and Detemir+Aspart insulin regimes in type 2 diabetics undergoing surgery.